publish

Health

The investor-to-state dispute settlement (ISDS) provisions proposed in trade agreements give pharmaceutical corporations the right to sue governments for compensation if domestic laws negatively affect future earnings on their intellectual property or investments, and even if these laws are in accordance with public interests. Better access to medicines or preventing unsafe or ineffective medicines from entering the market could prove problematic.

Major US, Canadian and French pharmaceutical companies have recently challenged pro-public health measures through ISDS disputes brought under ISDS provisions.

Chemical corporations have also used ISDS in numerous occasions to challenge national bans on hazardous substances.

Most well-known cases include:

• Ethyl (US) vs. Canada: following Canada’s ban on the toxic petrol additive MMT, the US producer sued for US$201 million in compensation. In 1998, Canada agreed in a settlement to pay US$13 million and withdrew the ban (NAFTA invoked).

• Philip Morris Asia (Hong Kong) vs. Australia: When Australia introduced plain packaging for all tobacco products in 2011, Philip Morris sued Australia before an arbitral tribunal. In its December 2015 decision, the tribunal dismissed the case, albeit on legal grounds only. Australia spent A$24 million in legal costs but Philip Morris only paid half, leaving the Australian taxpayers to pay the other half. As a consequence of this case, countries ranging from Namibia, Togo to New Zealand decided to wait to introduce their own plain packaging for tobacco products. (Australia-Hong Kong BIT invoked)

• Dow Chemical (US) vs. Canada: the chemical corporation initiated a dispute for losses it alleged were caused by a Quebec provincial ban on lawn pesticides containing the active ingredient 2,4-D, classified as a possible carcinogen and one of the ingredients in Agent Orange, the herbicide widely used during the Vietnam war. In a settlement in 2011, the ban was sustained but Quebec was required to state that “products containing 2,4-D do not pose an unacceptable risk to human health or the environment provided that the instructions on their label are followed.” (NAFTA invoked.)

Photo: Aqua Mechanical / CC BY 2.0

(March 2020)

Tobacco raises TPP concerns
Politico | 11-Oct-2014
US trade officials have denied they plan to offer a new tobacco proposal in the Trans-Pacific Partnership talks in Australia later this month.
corporate interests , CPTPP , health , investor-state disputes | ISDS
The international implications of the Philip Morris branding battle in Uruguay
World Trademark Review | 20-Sep-2014
Long-running litigation between Uruguay, which has some of the toughest anti-smoking laws in the world, and cigarette giant Philip Morris could have direct consequences for plain packaging legislation globally. Could it also pave the way for legal action in Europe?
Australia , health , Hong Kong , intellectual property , investor-state disputes | ISDS , Switzerland , Uruguay
Two-third of voters in Tory marginals want NHS exempt from US trade pact
The Guardian | 8-Aug-2014
More than two-thirds of voters in 13 battleground constituencies want to see the NHS safeguarded from a new trade deal that critics say threatens to make the privatisation of UK health services permanent.
health , investor-state disputes | ISDS , services , TTIP , UK
Comment l’industrie du tabac reprend l’offensive grâce aux traités de libre-échange
Basta ! | 10-Jul-2014
Les Etats membres de l’Union européenne pourront-ils continuer à développer leurs politiques de santé publique, notamment en matière de lutte anti-tabac ? Le Traité transatlantique, actuellement négocié avec les Etats Unis, inquiète.
health , investor-state disputes | ISDS , TTIP
Australia wins first battle in plain packaging trade dispute
Sydney Morning Herald | 3-Jul-2014
The Permanent Court of Arbitration has ordered that Australia will be allowed to challenge Philip Morris Asia’s right to contest Australia’s plain packaging laws, on the grounds that the company only bought shares in its Australian arm so that it could launch the case.
Australia , health , investor-state disputes | ISDS , US
Uruguay’s smoking laws draw tobacco fire
| 11-May-2014
While Uruguay has been celebrated by liberals around the world for its bold steps to regulate cannabis, with new rules taking effect this week, its similarly pioneering attempts to control smoking of another, legal plant – tobacco – has earned it powerful enemies.
corporate interests , health , ICSID , investor-state disputes | ISDS , Uruguay
NAFTA & environmental laws: Ethyl Corp. v. Government of Canada
Global Policy Forum | 30-Jan-2014
Chemical firm uses trade pact to contest Environmental Law
Canada , environment , health , investor-state disputes | ISDS , NAFTA | USMCA , US
CETA is more about corporate rights than free trade
| 9-Nov-2013
Since announcing the Comprehensive Economic and Trade Agreement (CETA) two weeks ago Harper’s Conservatives have repeatedly labelled those questioning the deal as “anti-trade”. But this Canada-European Union accord is one part trade and four parts ‘corporate bill of rights’.
Canada , corporate interests , EU , intellectual property , investment | BITs , investor-state disputes | ISDS , medicines
Trans-Pacific Partnership talks hit roadblock over anti-smoking policies
| 25-Aug-2013
Fast-moving trade talks aimed at reaching an ambitious Trans-Pacific Partnership trade deal have hit a major snag over anti-smoking policies, as divisions emerged over a proposal critics say would expose governments to lawsuits from tobacco companies.
CPTPP , health , investor-state disputes | ISDS
PMI awaits jurisdiction ruling in Uruguay bilateral investment treaty litigation
Tobacco Reporter | 19-Jun-2013
Philip Morris International expects a decision to be made this month or next on a challenge by Uruguay as to whether an international tribunal set to hear bilateral investment treaty complaints has jurisdiction over the matter.
health , investor-state disputes | ISDS , Uruguay , US